Barinthus Biotherapeutics plc - American Depositary Shares - Nakit Akışı (NASDAQ:BRNS)

Financials

İşletme faaliyetlerinden elde edilen nakit -32.58 M-14.43 M-50.92 M-28.94 M-47.98 M -36.44 M Yatırım faaliyetlerinden elde edilen nakit -12.91 M-5.75 M-5.41 M-892 K416 K 476 K Finansman faaliyetlerinden elde edilen nakit 222.74 M325 K1.87 M2.16 M2 000 0 Serbest nakit akışı -32.58 M-14.43 M-50.92 M-28.94 M-48.02 M -36.48 M

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

BRNS

Financials

Barinthus Biotherapeutics plc - American Depositary Shares

Haberler

Barinthus Biotherapeutics hissedarları düzenlemeyi onayladı

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

Barinthus Bio’nun çölyak tedavisi denemesinden olumlu ilk veriler geldi

Barinthus Bio reports positive initial data from celiac therapy trial

H.C. Wainwright, Barinthus Biotherapeutics için Al tavsiyesini yineledi

Barinthus Biotherapeutics stock rating reiterated at Buy by H.C. Wainwright

Barinthus Bio and Clywedog to merge in all-stock deal

Barinthus Biotherapeutics’ CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025